精神分裂症前额叶生长抑素神经元的诊断特异性与认知关联
该病例对照研究分析200例死后脑组织,发现精神分裂症患者背外侧前额叶浅层和深层生长抑素mRNA均降低,而双相障碍无此改变,重性抑郁仅浅层呈非显著性降低;仅精神分裂症浅层神经肽改变与较低教育程度相关。
要点
- 精神分裂症患者DLPFC浅层和深层SST mRNA均显著低于未患病个体。
- 双相障碍患者两区SST水平均未降低,重性抑郁仅浅层非显著降低。
- 仅精神分裂症浅层神经肽改变与较低教育程度(认知代理)相关。
核心结论
- DLPFC中SST神经元分子改变呈现诊断特异性模式,提示精神分裂症、重性抑郁和双相障碍涉及不同疾病过程。
- 在精神分裂症中,浅层SST神经元改变可能与认知功能障碍相关。
研究设计与样本
- 病例对照研究,使用2020年1月20日至2022年3月30日期间通过两个法医办公室从社区人群获得的死后脑组织标本。
- 共纳入200例标本:未患病对照65例、精神分裂症54例、重性抑郁42例、双相障碍39例;通过心理尸检获取人口学、临床和教育信息。
主要发现
- 与未患病个体相比,精神分裂症患者DLPFC浅层SST mRNA较低(Cohen d=0.68;95%CI 0.23-1.13;P=.004),深层也较低(Cohen d=0.60;95%CI 0.16-1.04;P=.02),FISH验证一致。
- 重性抑郁组仅浅层SST较低(Cohen d=0.58;95%CI 0.14-1.02;P=.12),但差异不显著;双相障碍组两区SST均未降低。
- 神经肽Y和速激肽1呈现相似模式。
- 仅在精神分裂症组中,浅层(而非深层)神经肽改变与较低教育程度相关(浅层:调整OR=1.71;95%CI 1.11-2.69;P=.02;深层:调整OR=1.08;95%CI 0.64-1.84;P=.77)。
临床怎么用
- 提示DLPFC浅层SST神经元分子改变可能作为精神分裂症认知功能障碍的病理关联指标。
- 诊断特异性模式有助于区分精神分裂症与双相障碍、重性抑郁的潜在分子差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Individuals with schizophrenia (SZ) exhibit pronounced deficits in somatostatin (SST) messenger RNA (mRNA) levels in the dorsolateral prefrontal cortex (DLPFC). Molecularly distinct subtypes of SST neurons, located in the superficial and deep zones of the DLPFC, are thought to contribute to different functional processes of this region; understanding the specificity of SST alterations in SZ across these zones could inform the functional consequences of those alterations, including cognitive impairments characteristic of SZ. OBJECTIVE: To quantify mRNA levels of SST and related neuropeptides in the DLPFC in individuals with SZ, bipolar disorder (BPD), or major depressive disorder (MDD) and unaffected comparison individuals. DESIGN, SETTING, AND PARTICIPANTS: This case-control study, conducted from January 20, 2020, to March 30, 2022, used postmortem brain tissue specimens previously obtained from individuals with SZ, MDD, or BPD and unaffected individuals from a community population through 2 medical examiners' offices. Demographic, clinical, and educational information was ascertained through psychological autopsies. EXPOSURES: Diagnosis of SZ, BPD, or MDD. MAIN OUTCOME AND MEASURES: The main outcome was levels of SST and related neuropeptide mRNA in 2 DLPFC zones, examined using laser microdissection and quantitative polymerase chain reaction or fluorescent in situ hybridization (FISH). Findings were compared using educational attainment as a proxy measure of premorbid cognition. RESULTS: A total of 200 postmortem brain specimens were studied, including 65 from unaffected comparison individuals (42 [65%] male; mean [SD] age, 49.2 [14.1] years); 54 from individuals with SZ (37 [69%] male; mean [SD] age, 47.5 [13.3] years); 42 from individuals with MDD (24 [57%] male; mean [SD] age, 45.6 [12.1] years); and 39 from individuals with BPD (23 [59%] male; mean (SD) age, 46.2 [12.5] years). Compared with unaffected individuals, levels of SST mRNA were lower in both superficial (Cohen d, 0.68; 95% CI, 0.23-1.13; P = .004) and deep (Cohen d, 0.60; 95% CI, 0.16-1.04; P = .02) DLPFC zones in individuals with SZ; findings were confirmed using FISH. Levels of SST were lower only in the superficial zone in the group with MDD (Cohen d, 0.58; 95% CI, 0.14-1.02; P = .12), but the difference was not significant; SST levels were not lower in either zone in the BPD group. Levels of neuropeptide Y and tachykinin 1 showed similar patterns. Neuropeptide alterations in the superficial, but not deep, zone were associated with lower educational attainment only in the group with SZ (superficial: adjusted odds ratio, 1.71 [95% CI, 1.11-2.69]; P = .02; deep: adjusted odds ratio, 1.08 [95% CI, 0.64-1.84]; P = .77). CONCLUSIONS AND RELEVANCE: The findings revealed diagnosis-specific patterns of molecular alterations in SST neurons in the DLPFC, suggesting that distinct disease processes are reflected in the differential vulnerability of SST neurons in individuals with SZ, MDD, and BPD. In SZ, alterations specifically in the superficial zone may be associated with cognitive dysfunction.
引用
- Dienel SJ, Dowling KF, Barile Z, et al. Diagnostic Specificity and Association With Cognition of Molecular Alterations in Prefrontal Somatostatin Neurons in Schizophrenia. JAMA Psychiatry. 2023. PMID: 37647039. doi:10.1001/jamapsychiatry.2023.2972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。